Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • Suppliers
    • The Big 100
      • Archive – The Big 100 (2018)
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • Leadership
    • Women in Medtech
    • 2020 Winners
    • 2019 Winners

The 10 hottest medtech startups of 2017

April 21, 2017 By Heather Thompson

Newly formed cochlear hair cells contain intricate hair bundles with many stereocilia (critical for sensing sound) and other components that are critical for proper function and neural transmission. [Image courtesy of Will McLean/Frequency Therapeutics]

Frequency Therapeutics

Technology: Progenitor cell activation to treat hearing loss

CEO: David Lucchino

Website: www.frequencytx.com

Frequency Therapeutics is developing a pipeline of new drugs that activate progenitor cells within the body. The therapy has promise for a range of therapeutic indications for skin disorders, muscle regeneration and gastrointestinal diseases. Its lead product candidate stimulates regrowth of sensory hair cells in the inner ear to treat chronic noise-induced hearing loss.

Chronic noise-induced hearing loss is a significant disease effecting 48 million people in the United States and roughly 1.1 billion globally.

Frequency’s progenitor cell activation (PCA) is a precise and controlled approach that transiently causes Lgr5+ progenitor cells to divide and differentiate, as with naturally regenerating tissues such as the skin and intestine. It essentially mimics “stemness” in the body, potentially yielding an entirely new category of disease-modifying therapeutics for a wide range of degenerative conditions. The small molecules could have similar effects as gene therapy and CRISPR, with easier delivery. The hearing loss indication is moving to clinical trials within the next 12 to 18 months.

Company officials believe there is a broad potential for the PCA platform and announced the closing of a $32 million Series A financing in April to help expand its research.

Next>>

Pages: 1 2 3 4 5 6 7 8 9 10 11

Comments

  1. juan ernesto says

    November 15, 2017 at 5:18 pm

    Heather, great insights on the changing needs for medtech start-ups. We were thrilled to see, Madorra, one of our collaborating partners make your top 10. Look forward to following your updates on this incredible startup space.

    • Heather Thompson says

      November 15, 2017 at 6:33 pm

      They are doing some important work. Thanks, Juan. I’m excited to see the latest crop of startups for 2018 as well.

Related Articles Read More >

coronavirus COVID-19 FDA HHS tests
The top 7 medtech CEO quotes on COVID-19, one year later
robotic surgery robot-assisted surgery Medtronic Intuitive Surgical Stryker Corindus Vascular Robotics
12 surgical robotics companies you need to know
talus-implant
FDA gives ankle implant humanitarian nod
DTW Podcast: Zimmer Biomet slims, Corza Medical grows in pursuit of market share

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Tweets by MedTechDaily

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Medical Tubing + Extrusion
  • MedTech 100
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertising
  • Subscribe to Enewsletter
  • Subscribe to Print Magazine
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our Device Talks Tuesdays Discussion

Copyright © 2021 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • Suppliers
    • The Big 100
      • Archive – The Big 100 (2018)
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • Leadership
    • Women in Medtech
    • 2020 Winners
    • 2019 Winners